"","scenario","cases","severe_disease","hosp","death","YLL"
"1","25% prioritisation"," -15,543 (-0.2%)","  -1,393 (-4.9%)","  -2,932 (-2.2%)","    -151 (-7.2%)","  -1,420 (-5.1%)"
"2","50% prioritisation"," -13,656 (-0.1%)","  -1,433 (-5%)","  -2,988 (-2.2%)","    -155 (-7.4%)","  -1,463 (-5.2%)"
"3","75% prioritisation"," -12,513 (-0.1%)","  -1,444 (-5.1%)","  -2,999 (-2.2%)","    -157 (-7.5%)","  -1,475 (-5.3%)"
"4","booster at three months (at risk only)"," -96,437 (-1%)","  -7,220 (-25.3%)"," -14,872 (-11.2%)","    -776 (-36.9%)","  -7,239 (-25.9%)"
"5","additional primary doses"," -23,724 (-0.2%)","  -1,492 (-5.2%)","  -3,289 (-2.5%)","    -157 (-7.5%)","  -1,506 (-5.4%)"
"6","additional booster doses","-123,242 (-1.3%)","  -7,206 (-25.3%)"," -15,536 (-11.7%)","    -754 (-35.9%)","  -7,136 (-25.6%)"
"7","broaden to <18 pregnant individuals"," -23,724 (-0.2%)","  -1,492 (-5.2%)","  -3,289 (-2.5%)","    -157 (-7.5%)","  -1,506 (-5.4%)"
